The AmiGuard Platform is a series of new indications for FDA-approved Amifostine to 

protect against radiation induced damage to cells and enhance the fidelity of repair for cells exposed to radiation.

  • CT scans have been proven to cause RIGDI, which marks the beginning stages of carcinogenesis.
  • CT scans are an essential diagnostic tool, yet CT scanning has been proven to meaningfully contribute to the risks and probability of developing cancer.